These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3698703)

  • 1. Antileukoprotease in sputum during bronchial infections.
    Dijkman JH; Kramps JA; Franken C
    Chest; 1986 May; 89(5):731-6. PubMed ID: 3698703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease.
    Piccioni PD; Kramps JA; Rudolphus A; Bulgheroni A; Luisetti M
    Chest; 1992 Nov; 102(5):1470-6. PubMed ID: 1385052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal sequence of antileukoprotease isolated from bronchial secretion.
    Klasen EC; Kramps JA
    Biochem Biophys Res Commun; 1985 Apr; 128(1):285-9. PubMed ID: 3985970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileukoprotease is associated with elastin fibers in the extracellular matrix of the human lung. An immunoelectron microscopic study.
    Kramps JA; Te Boekhorst AH; Fransen JA; Ginsel LA; Dijkman JH
    Am Rev Respir Dis; 1989 Aug; 140(2):471-6. PubMed ID: 2764383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the role of antileukoprotease in respiratory tract diseases.
    Fryksmark U; Prellner T; Tegner H; Ohlsson K
    Eur J Respir Dis; 1984 Apr; 65(3):201-9. PubMed ID: 6202540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antileukoprotease in connective tissue of the lung.
    Willems LN; Otto-Verberne CJ; Kramps JA; ten Have-Opbroek AA; Dijkman JH
    Histochemistry; 1986; 86(2):165-8. PubMed ID: 2434453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of masked specific proteinase inhibitor from bronchial secretions in purulent sputum as complex with leucocytic proteinases.
    Hochstrasser K; Schorn K; Rasche B; Lemparth K; Raffelt Ch
    Pneumonologie; 1975 Sep; 152(1-3):15-24. PubMed ID: 1187387
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.
    Stockley RA; O'Brien C; Pye A; Hill SL
    Chest; 2000 Jun; 117(6):1638-45. PubMed ID: 10858396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mucosal defence capacity against proteolytic leukocyte enzymes.
    Tegner H; Fryksmark U; Ohlsson K
    Eur J Respir Dis Suppl; 1985; 139():62-5. PubMed ID: 3876236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies.
    De Water R; Willems LN; Van Muijen GN; Franken C; Fransen JA; Dijkman JH; Kramps JA
    Am Rev Respir Dis; 1986 May; 133(5):882-90. PubMed ID: 3706899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).
    Fritz H
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():79-82. PubMed ID: 3060147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antileukoprotease in surgical lung specimens.
    Willems LN; Kramps JA; de Water R; Stijnen T; Fleuren GJ; Franken C; Dijkman JH
    Eur J Respir Dis; 1986 Oct; 69(4):242-7. PubMed ID: 3817059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteolytic and antiproteolytic potential of the sputum in chronic bronchitis patients during exacerbation].
    Khomenko AG; Kaminskaia GO; Pylluste IaA; Zhukova NL; Ozerova LV
    Ter Arkh; 1983; 55(3):60-3. PubMed ID: 6344303
    [No Abstract]   [Full Text] [Related]  

  • 15. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
    Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
    Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileukoprotease in patients with maxillary sinusitis.
    Fryksmark U; Jannert M; Ohlsson K; Tegner H
    Rhinology; 1985 Sep; 23(3):247-51. PubMed ID: 3851511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome].
    Rasche B; Hochstrasser K; Marcic I; Ulmer WT
    Respiration; 1975; 32(5):340-54. PubMed ID: 1080869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.
    Stockley RA; Morrison HM; Kramps JA; Dijkman JH; Burnett D
    Thorax; 1986 Jun; 41(6):442-7. PubMed ID: 2431494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchorrhoea.
    Lopez-Vidriero M; Charman J; Keal E; Reid L
    Thorax; 1975 Dec; 30(6):624-30. PubMed ID: 176747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.
    Gompertz S; Bayley DL; Hill SL; Stockley RA
    Thorax; 2001 Jan; 56(1):36-41. PubMed ID: 11120902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.